Two U.S. House members who first pushed the Food and Drug Administration in 2023 to investigate the health risks of hair straighteners used primarily by Black women are asking the agency why it has twice delayed its target date to propose a ban on products containing formaldehyde.

The parents of Kentucky baby who died last fall after drinking bacteria-tainted infant formula are the latest to sue manufacturer Abbott Nutrition.

The Food and Drug Administration has finalized a rule to regulate medical tests that have long escaped oversight.

The Food and Drug Administration says it plans to begin regulating laboratory-based medical tests.

A tornado that tore through eastern North Carolina and struck a large Pfizer pharmaceutical plant has damaged its drug storage facility but not its medicine production areas.

The Food and Drug Administration is ordering an unproven drug intended to prevent premature births off the market.

The Food and Drug Administration is pledging a reset in the agency’s tobacco program.

Draft U.S. rules would allow soy, oat, almond and other drinks that bill themselves as “milk” to keep using the name.

The U.S. Food and Drug Administration is taking aim at a new health hazard: online misinformation.

The head of the Food and Drug Administration has announced an overhaul of the agency's food safety and nutrition division.

The Food and Drug Administration's top food safety official has resigned.

A new report criticizes the Food and Drug Administration’s efforts to oversee the tobacco industry, including traditional cigarettes and vaping products.

The Food and Drug Administration is slowing its use of a pathway that expedites the approval of promising drugs.

A panel is calling for changes at the federal agency that oversees most of the nation's food supply, saying revamped leadership, a clear mission and more urgency are needed to prevent illness outbreaks and to promote good health.

A panel of federal advisers says a pregnancy drug intended to prevent premature births should be withdrawn because it doesn't work.

U.S. regulators have revealed their plan to allow foreign baby formula manufactures to stay on the market long term.

The new chief at the Food and Drug Administration's tobacco center has inherited a raft of problems.

U.S. health regulators say their response to the ongoing infant formula shortage was slowed by delays in processing a whistleblower complaint and test samples from the nation’s largest formula factory.

U.S. health officials are warning doctors against overusing the lone drug available to treat monkeypox.

The head of the Food and Drug Administration says a government review of prescription opioid medications, including their risks and contribution to the U.S. overdose epidemic, is still underway.

U.S. regulators have issued a warning letter to the maker of illegal nicotine gummies.

The head of the Food and Drug Administration says a comprehensive review of the opioid painkillers that triggered the nation's ongoing overdose epidemic is in the works.

The head of the Food and Drug Administration is asking for a review of the agency’s food and tobacco programs.

The U.S. is getting another COVID-19 vaccine choice.

U.S. regulators have historically inspected baby formula plants at least once a year, but they did not inspect any of the three biggest manufacturers in 2020.

Abbott says it's restarted production at the Michigan factory that's tied to the ongoing baby formula shortage.

The head of the Food and Drug Administration testified about a series of setbacks that led to a months-long delay in inspecting the plant at the center of a nationwide baby formula shortage.

The Food and Drug Administration's commissioner says a shuttered baby formula factory could be up and running by next week.

President Joe Biden's administration has announced new steps to ease the national shortage of baby formula, including allowing more imports from overseas.

The U.S. government has released its long-awaited plan to ban menthol cigarettes and flavored cigars.

Vacant high-ranking positions across the executive branch could be taking a toll on the Biden administration.

The Senate has narrowly confirmed President Joe Biden’s pick to lead the Food and Drug Administration, filling a position that had been open for more than a year.

President Joe Biden’s pick to lead the powerful Food and Drug Administration has stalled in the narrowly divided Senate.

President Joe Biden’s pick to lead the Food and Drug Administration deftly parried questions on crises ranging from the COVID pandemic to the opioid epidemic.

President Joe Biden is nominating former Food and Drug Administration Commissioner Dr. Robert Califf to again lead the powerful regulatory agency.